Abstract P5-09-28: A phase I, prospective exploratory clinical study of neoadjuvant pyrotinib plus trastuzumab, dalpiciclib, and letrozole for patients with HR-positive, HER2-positive early or locally advanced breast cancer
Year: 2025
Type: conference-abstract
Source: Clinical Cancer Research
Authors: Guangdong Qiao, Jun Lin, Haidong Zou, Yalun Li, Zhi Liang, Xingmiao Wang, Ge Gao, Kun Zhang, Yeqing Zhou, Yidan Wang, Song Zhang, Feng Li, Xiang Bi, Xiaohui Li, Shengqun Yu, Yansheng Li, Chunxin Qin, Kai Cheng
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4411288972